α5β1 integrin-IN-1
α5β1 integrin-IN-1 is a potent and selective α5β1 integrin inhibitor with an IC50 value of approximately 0.4 nM (pIC50 = 9.4 M). α5β1 integrin-IN-1 disrupts the interaction between α5β1 integrin and fibronectin, thereby blocking smooth muscle tension transmission and α5β1 integrin-mediated cell adhesion. α5β1 integrin-IN-1 can be used in the research of asthma and allergic asthma.
For research use only. We do not sell to patients.
- CAS No.: 2649899-08-9
- Formula: C29H27Cl2FN6O5
- Molecular Weight:629.47
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[2]|
α5β1 0.4 nM (IC50) |
αvβ3 5500 mM (pIC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| SW480 | IC50 |
0.4 nM
|
Inhibition of α5β1-mediated cell adhesion to fibronectin in human SW480 colon adenocarcinoma cells via crystal violet staining assay with 15 min pre-incubation and 1 h adhesion incubation.
Inhibition of α5β1-mediated cell adhesion to fibronectin in human SW480 colon adenocarcinoma cells via crystal violet staining assay with 15 min pre-incubation and 1 h adhesion incubation.
|
41427225 |
In Vitro
α5β1 integrin-IN-1 (Compound 65) at 30 μM exhibits only extremely weak inhibitory activity against hERG channels in hERG-expressing cells, with an inhibition rate of 6.11%.
α5β1 integrin-IN-1 (30 μM) does not inhibit hERG ion channel activity at concentrations up to 30 μM.
α5β1 integrin-IN-1 (up to 1000 μg/well) shows no mutagenicity in the Ames test.
α5β1 integrin-IN-1 (10 μM; 5-45 min) does not inhibit the activity of CYP subtypes at a concentration of 10 μM.
α5β1 integrin-IN-1 (pre-incubated at 4°C for 15 min, followed by incubation at 37°C for 1 h) exhibits high α5β1 receptor selectivity in β3-transfected SW480 cells plated on fibrinogen, HT1080 cells plated on rat tail collagen I, SW480 cells plated on vitronectin, and human α4-transfected SW480 cells plated on VCAM-1, with an IC50 of approximately 0.4 nM (pIC50 = 9.4 M).
α5β1 integrin-IN-1 (100 µM) exhibits specific transmembrane permeability and efflux effects in the Caco-2 cell model.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Parmacokinetics
| Species | Dose | Route | Tmax | Cmax | T1/2 | AUCinf | F |
|---|---|---|---|---|---|---|---|
| Mice[1] | 2 mg/kg | i.n. | 0.083 h | 916 ng/mL | 1.01 h | 326 ng/mL·h | 122 % |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (sex-matched, 7 weeks old, ovalbumin-sensitized and challenged)[1]
-
Dosage:1 mg/kg
-
Administration:i.n.; single dose
-
Result:Significantly reduced respiratory system resistance compared to the ovalbumin/vehicle group (P < 0.01).
Showed no significant differences in inflammatory markers, including BAL cell count and differential, serum IgE level, histology, or PAS score, compared to vehicle-treated mice.
Chemical Information
-
CAS No. 2649899-08-9
-
Molecular Weight 629.47
-
Formula C29H27Cl2FN6O5
-
SMILES
ClC1=C(C(N[C@@H](CNC(CNC(C2=CC(NC3=NCC(F)CN3)=CC=C2)=O)=O)C(O)=O)=O)C(Cl)=CC(C4=CC=CC=C4)=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Ovalbumin-Induced Allergic Airway Inflammation
Ovalbumin-induced allergic airway inflammation is a mouse model in which systemic sensitization to ovalbumin, usually with aluminum hydroxide adjuvant, is followed by airway ovalbumin challenge to induce allergic airway inflammation, eosinophil recruitment, mucus production, serum antigen-specific IgE, Th2 cytokine responses, and airway hyperresponsiveness to methacholine. The model is used to study allergen-driven airway inflammation and asthma-like immune responses, but it does not reproduce every feature of human asthma. The main readouts are bronchoalveolar lavage fluid cellularity, lung histopathology, airway hyperresponsiveness, serum OVA-specific IgE, and cytokines such as IL-4, IL-5, and IL-13 in bronchoalveolar lavage fluid or lung samples. Eosinophilia and Th2 cytokines reflect allergic type 2 inflammation, while methacholine responsiveness provides a functional airway-reactivity endpoint.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)